A Multiple Dose Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in Subjects With Type 2 Diabetes

Clinical trial NCT01796366 · COMPLETED

Trial details

NCT number

NCT01796366

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2013-02-21

Primary completion

2013-08-19

Enrollment

40

View on ClinicalTrials.gov